- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04833595
Can Mindful Eating Improve Cholesterol and Glucose Level
Can Mindful Eating Improve Cholesterol and Glucose Level: A Tele-Health Pilot-Randomised Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Consistently high cholesterol or/and glucose level pose harmful threat to the body that may cause lethal health conditions (e.g. stroke, cardiovascular diseases). In addition, 3.6 million Malaysians are suffering from diabetes, the highest rate of incidence in Asia and one of the highest in the world. There is crucial need to find ways to improve the situation. Tele-health interventions and mindful eating behaviours are proposed to be effective in improving the levels of cholesterol and glucose. To investigate and explore the intervention, a small-scale randomised controlled trial will be conducted by comparing the effectiveness of mindful eating and the effect on cholesterol and glucose level. Students will collect and analyse both quantitative and qualitative data.
A small-scale randomised controlled trial will be conducted to compare the effectiveness of mindful eating and the effect on lipid level. Subjects will be randomly assigned to intervention or control group. For intervention group, subjects will be required to snap picture of every meal that they consume. At the end of the day, they are required to actively recall and reflect on how healthy they consider their meals to be. The reflection will be submitted to the research team daily together with the taken pictures of meal. As for the control group, subjects will only snap and submit the picture of their meals but without active recall and reflection.
Subjects are required to return to the community pharmacy after two months to follow-up on their glucose and lipid levels post intervention.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Phaik Eong Poh, PhD
- Phone Number: +603 5514 6272
- Email: poh.phaik.eong@monash.edu
Study Locations
-
-
Selangor
-
Subang Jaya, Selangor, Malaysia, 47500
- Recruiting
- Monash University Malaysia
-
Contact:
- Siew Li Teoh, MPharm, PhD
- Phone Number: (+603) 5515-9646
- Email: teoh.siew.li@monash.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Total fasting cholesterol of at least 5.2mmol/L
Exclusion Criteria:
- Familial hypercholesterolaemia or Pregnant women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness Arm
A recommendation on healthy food intake will be sent to participants. At the end of each week, participants will be required 1) to submit THREE photos of the meals that they are most satisfied with in terms of healthiness and 2) using the photos to answer a questionnaire about their diet. The photos and completed questionnaire must be submitted to the research investigator each week for a total of 8 weeks. After 8 weeks, participants will be required to get tested for your fasting total cholesterol and blood glucose level in the appointed pharmacy for the second time. It is estimated to require 15-30 minutes of their time weekly. The questionnaire used for experimental group contains reflective questions as part of the mindfulness intervention. |
Mindfulness is hypothesised to include reflective practice.
Therefore, reflective questions are asked in the questionnaire for intervention group but not for control group.
|
Active Comparator: Non-mindfulness Arm
Everything is similar to the experimental arm.
However, the questionnaire used for control group does not contain reflective questions to serve as control group.
|
Mindfulness is hypothesised to include reflective practice.
Therefore, reflective questions are asked in the questionnaire for intervention group but not for control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting total cholesterol
Time Frame: 8 weeks
|
Total cholesterol taken after at least 8 hours fasting
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting glucose
Time Frame: 8 weeks
|
Blood glucose taken after at least 8 hours fasting
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Phaik Eong Poh, PhD, Monash University Malaysia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27779
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholesterol; Lipidosis
-
University of TorontoUnknownCardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
Children's Mercy Hospital Kansas CityRecruiting
-
Libbs Farmacêutica LTDACompletedArterial Hypertension | Blood Glucose, High | Cholesterol; LipidosisBrazil
-
University of AlicanteCompletedHypertension | Obesity | Body Weight | Diet, Healthy | Machine Learning | Cholesterol; LipidosisSpain
-
University of TorontoUnknownCardiovascular Diseases | Stroke | Inflammation | Diabetes | Blood Pressure | Coronary Heart Disease | Adiposity | Cardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
Pamukkale UniversityBakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedType2 Diabetes | Self Efficacy | Self Management | Cholesterol; Lipidosis | High Density Lipoprotein Deficiency | Motivational Interview | Tele-nursing | LDL - Low Density Lipoprotein Receptor DisorderTurkey
-
Texas A&M UniversityCompletedCholesterol, LDL | Cholesterol, HDL | Research SubjectsUnited States
-
Universidad Católica San Antonio de MurciaCompleted
-
Organon and CoSchering-PloughCompletedCholesterol
-
Organon and CoSchering-PloughCompleted
Clinical Trials on Mindfulness practice
-
Duke UniversityTerminatedMental Disorders | Depression | AnxietyUnited States
-
Michigan State UniversityCompletedStress | AnxietyUnited States
-
Hospital Israelita Albert EinsteinUnknownHemodialysis Complication | Emotional StressBrazil
-
Jeanmarie R. Burke, PhDCompleted
-
University of Wisconsin, MadisonRecruitingDepression | Burnout, Student | AnxietyUnited States
-
Sha Research FoundationActive, not recruitingQuality of Life | Telomere LengthCanada
-
Duke UniversityCompletedObesity | Stigma, SocialUnited States
-
University of MelbourneNot yet recruitingDepression | Well-Being, Psychological
-
Yale-NUS CollegeDuke-NUS Graduate Medical SchoolCompleted